Please assess the completion status of the following clinical trial:

Trial Title: Reduction of Bacteria in MRSA Positive Ulcers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Must have given written informed consent~* Must be 19 years of age or over~* Must have an ulcer or lesion in which the presence of MRSA has been positively identified but which is not clinically infected.~* Must have an Ulcer / Lesion size not to extend beyond the inner borders of the wound cover~Exclusion Criteria:~* Is a female who is pregnant, nursing, or of child bearing potential who is not using an adequate form of contraception (or abstinence)~* Is \< 19 years of age~* Has a clinically infected ulcer~* Has an Ulcer / Lesion that is currently treated or has been treated with a topical antimicrobial agent during 3 days prior to enrolment.~* Has been using systemic antibiotics during 7 days prior to enrolment into this study.~* Has an Ulcer / Lesion which is identified as malignant in origin (e.g., Marjolin's ulcer)~* Has an Ulcer / Lesion size beyond the inner borders of the wound cover~* Is septic or has other signs of an invasive infection~* Has used any other investigational product within 30 days preceding study participation.~* Suffers from a condition, which, in the opinion of the Investigator,would compromise his or her safety.~* Suffers from a condition which, in the opinion of the Investigator, would compromise the quality of the data.~* Has a known allergy to any of the products that are part of this protocol~* Suffers from a condition which, in the opinion of the Investigator, would seriously interfere negatively with the normal parameters of immune response to an infection.~* Is using any of the prohibited concomitant medications or treatments

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Nitric Oxide (Type: EXPERIMENTAL): gaseous nitric oxide delivered topically for 30 minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).